Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Adjunctive Therapy in MDD
NCT00105196Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Mar 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in major depressive disorder (MDD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Mar 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00105196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105196.